GlaxoSmithKline Pharmaceuticals informs about issuance of duplicate share certificates

28 Nov 2022 Evaluate

Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), GlaxoSmithKline Pharmaceuticals has informed that Registrar and Transfer Agent of Company - KFin Technologies has received request for issue of duplicate Share Certificates from Shareholder. The company will issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s). Details of the same are enclosed.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2447.05 -17.85 (-0.72%)
29-Dec-2025 11:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.60
Dr. Reddys Lab 1262.95
Cipla 1501.80
Zydus Lifesciences 905.45
Lupin 2092.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×